Sat.Nov 16, 2024

article thumbnail

First U.S. case of new mpox strain detected in California

STAT

California has detected the country’s first case of a new mpox strain that is spreading from person to person. The infected individual had recently traveled from Eastern Africa, where multiple countries are battling transmission of this virus. The individual was treated in a health facility in San Mateo County and is in isolation at home, the California Department of Public Health announced in a statement released Saturday.

338
338
article thumbnail

Frontier Scientific Solutions Plans a Global Free Trade Zone Gateway to Supply Life Sciences Industry on Back of $1.5 Billion Investment

PharmaTech

Frontier Scientific Solutions has unveiled plans to use a $1.5 billion commitment from a major investor to create a global free trade zone gateway to facilitate the life sciences supply chain using Wilmington International Airport in North Carolina.

52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

STAT+: Intellia says CRISPR therapy shows superior gain for cardiomyopathy patients

STAT

Intellia Therapeutics CEO John Leonard has, for the last couple years, found himself stuck in a financial Groundhog Day. Repeatedly, the company has announced positive data from its gene editing trials, only to watch the stock slide.  The stock market is notoriously fickle, particularly around buzzy gene-editing companies. Yet the selloffs pointed to real questions around the biotech’s programs: Clearly, its CRISPR-based drugs were effective.

261
261
article thumbnail

EMA’s CHMP Gives Positive Opinion for Use of Lecanemab in Early Alzheimer’s Disease

PharmaTech

CHMP has granted Eisai Europe and Biogen a positive opinion for the use of their monoclonal antibody therapy in treating early Alzheimer’s disease.

52
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

AHA 2024: Tirzepatide Lowers Risk of Worsening Heart Failure, CVD Death in Adults With Obesity

Pharmacy Times

This is the first trial that tested the effect of any medication on major heart failure outcomes in patients with HFpEF and obesity, according to investigators.

58
article thumbnail

What to know about RFK Jr.’s views on food, vaccines, abortion, and the FDA

STAT

President-elect Trump’s announcement that he plans to nominate Robert F. Kennedy Jr. to lead the Department of Health and Human Services unleashed both applause and alarm on Thursday. If the Senate approves the nomination, RFK Jr. is poised to reshape public health agencies and could usher in a new era for vaccines and medicines.  RFK Jr. said Thursday that he looks “forward to working with the more than 80,000 employees at HHS to free the agencies from the smothering cloud of

Vaccines 348

More Trending

article thumbnail

AHA 2024: Unexplained Changes in Cholesterol Could Help Identify Adults At Risk of Dementia

Pharmacy Times

High fluctuations (in the top 25%) in total cholesterol were associated with a 60% increase in dementia and a 23% increase in cognitive decline.

26
article thumbnail

AHA 2024: Providing Feedback for Pharmacists Improved Care for Veterans With Heart Failure

Pharmacy Times

Within the Veterans Health Administration System, primary care pharmacists are embedded in primary care panels and work alongside primary care physicians and nurses to optimize medication management for patients.

29
article thumbnail

FDA REMS Program Shows Promising Results for Mavacamten in Hypertrophic Cardiomyopathy Treatment

Pharmacy Times

Milind Desai, MD, MBA shares insight into the REMS program for patients with obstructive hypertrophic cardiomyopathy.

29